<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">138464</id>
  <title nil="true"/>
  <common-name>AZD-5153</common-name>
  <description>AZD-5153 is an organic compound with the formula C25H33N7O3 and an average molecular weight of 479.58 g/mol. AZD-5153 belongs to the phenylpiperidines, a subclass of piperidines within the organic compounds. Classified as an organoheterocyclic compound, it functions as an inhibitor of Bromodomain-containing protein 4 (BRD4).</description>
  <cas>1869912-39-9</cas>
  <pubchem-id>118693659</pubchem-id>
  <chemical-formula>C25H33N7O3</chemical-formula>
  <weight>479.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T21:09:51Z</created-at>
  <updated-at type="dateTime">2026-08-22T05:24:44Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB17018</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=NN=C2C=CC(=NN12)N1CCC(CC1)C1=CC=C(OCCN2CCN(C)C(=O)[C@H]2C)C=C1</moldb-smiles>
  <moldb-formula>C25H33N7O3</moldb-formula>
  <moldb-inchi>InChI=1S/C25H33N7O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23/h4-9,18,20H,10-17H2,1-3H3/t18-/m1/s1</moldb-inchi>
  <moldb-inchikey>RSMYFSPOTCDHHJ-GOSISDBHSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">479.585</moldb-average-mass>
  <moldb-mono-mass type="decimal">479.264487951</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.57</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM134357</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(3R)-4-{2-[4-(1-{3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}piperidin-4-yl)phenoxy]ethyl}-1,3-dimethylpiperazin-2-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Piperidines</klass>
  <subklass>Phenylpiperidines</subklass>
  <paper-count type="integer">395</paper-count>
  <sync-id>CED0012109</sync-id>
  <structure-inchikey>RSMYFSPOTCDHHJ-GOSISDBHSA-N</structure-inchikey>
  <structure-fingerprint>4040000000000000000800002000000020000008000000000200000000000000000000000040020201100000000002000010108000000008000000000000000000100008000000000000000004000100020000000000100000200000000000000000004200010000048000000020200000000020100000000000080000000100020000040000000000000000000004002080100800000000000000000004001000000040004000000000000080000000000000000080000008000000000000080000000000000000000000000000000000000040000000000000200000000800010000000800000200040020000000000000000080000000000800002000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJwAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:50:46Z</structure-indexed-at>
</compound>
